These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacokinetic profiling of efavirenz-emtricitabine-tenofovir fixed dose combination in pregnant and non-pregnant rats. Nirogi R; Bhyrapuneni G; Kandikere V; Muddana N; Saralaya R; Komarneni P; Mudigonda K; Mukkanti K Biopharm Drug Dispos; 2012 Jul; 33(5):265-77. PubMed ID: 22610784 [TBL] [Abstract][Full Text] [Related]
23. The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit. Szeto HH; Umans JG; Rubinow SI Drug Metab Dispos; 1982; 10(4):382-6. PubMed ID: 6126338 [TBL] [Abstract][Full Text] [Related]
24. Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications. Koren G; Pariente G Pharm Res; 2018 Feb; 35(3):61. PubMed ID: 29435666 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of drugs in pregnancy. Feghali M; Venkataramanan R; Caritis S Semin Perinatol; 2015 Nov; 39(7):512-9. PubMed ID: 26452316 [TBL] [Abstract][Full Text] [Related]
27. Drug delivery during pregnancy: evaluation in vitro of new drugs. Dancis J; Liebes L Reprod Fertil Dev; 1995; 7(6):1485-9. PubMed ID: 8743151 [TBL] [Abstract][Full Text] [Related]
28. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women. Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404 [TBL] [Abstract][Full Text] [Related]
29. Physiological changes during pregnancy and their implications for pharmacological treatment. Redmond GP Clin Invest Med; 1985; 8(4):317-22. PubMed ID: 4075616 [TBL] [Abstract][Full Text] [Related]
30. Research on pharmacokinetics during pregnancy. Nöschel H; Peiker G; Voigt R; Meinhold P; Müller B; Schröder S; Bonow A Arch Toxicol Suppl; 1980; 4():380-4. PubMed ID: 6933942 [TBL] [Abstract][Full Text] [Related]
31. [Drug effects on embryo and fetus. 2. Diaplacental transport of drugs]. Reinhardt D; Richter O Fortschr Med; 1981 Sep; 99(35):1394-8. PubMed ID: 7274943 [TBL] [Abstract][Full Text] [Related]
32. Hypoglycemics: pharmacokinetic considerations during pregnancy. Klieger C; Pollex E; Kazmin A; Koren G Ther Drug Monit; 2009 Oct; 31(5):533-41. PubMed ID: 19730277 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic considerations in the maternal-placental-fetal unit. Juchau MR; Faustman-Watts E Clin Obstet Gynecol; 1983 Jun; 26(2):379-90. PubMed ID: 6851290 [No Abstract] [Full Text] [Related]
34. Placental drug transporters. Unadkat JD; Dahlin A; Vijay S Curr Drug Metab; 2004 Feb; 5(1):125-31. PubMed ID: 14965255 [TBL] [Abstract][Full Text] [Related]
35. Drug metabolism by the human fetus. Juchau MR; Chao ST; Omiecinski CJ Clin Pharmacokinet; 1980; 5(4):320-39. PubMed ID: 6994979 [TBL] [Abstract][Full Text] [Related]
36. Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation. Anderson GD Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):947-60. PubMed ID: 17125410 [TBL] [Abstract][Full Text] [Related]